Literature DB >> 19668153

Brand biologics grab 12 years' exclusivity, for now.

Randy Osborne.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19668153     DOI： 10.1038/nbt0809-677

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

Review 1.  Follow-on biologics: data exclusivity and the balance between innovation and competition.

Authors:  Henry Grabowski
Journal:  Nat Rev Drug Discov       Date:  2008-05-12       Impact factor: 84.694
  1 in total
  2 in total

1.  WHO guidelines presage US biosimilars legislation?

Authors:  John Hodgson
Journal:  Nat Biotechnol       Date:  2009-11       Impact factor: 54.908

Review 2.  The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond.

Authors:  Lin-Chau Chang
Journal:  J Food Drug Anal       Date:  2019-04-30       Impact factor: 6.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.